BamSEC and AlphaSense Join Forces
Learn More

Bolt Biotherapeutics Inc. – Material Contracts

NASDAQ: BOLT    
Share price (8/10/26): $3.99    
Market cap (8/10/26): $7.667 million

Material Contracts Filter

EX-10.2
from 8-K 8 pages Bolt Biotherapeutics, Inc. Consulting Agreement
12/34/56
EX-10.1
from 8-K 8 pages Bolt Biotherapeutics, Inc. Consulting Agreement
12/34/56
EX-10
from 10-K 3 pages First Amendment to Lease Agreement
12/34/56
EX-10
from 10-K 26 pages For Purposes of the Plan, the Following Terms Are Defined as Follows
12/34/56
EX-10.1
from 10-Q 2 pages Certain Confidential Information Contained in This Documents, Marked by [***], Has Been Omitted Because Bolt Biotherapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Bolt Biotherapeutics, Inc. if Publicly Disclosed. Certain Confidential Information Contained in This Documents, Marked by [***], Has Been Omitted Because Bolt Biotherapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Bolt Biotherapeutics, Inc. if Publicly Disclosed
12/34/56
EX-10.1
from 10-Q 24 pages Amended and Restated Supply Agreement
12/34/56
EX-10.1
from 8-K 9 pages Bolt Biotherapeutics, Inc. Consulting Agreement Effective Date: March 3, 2022
12/34/56
EX-10.7
from S-1/A 13 pages Bolt Biotherapeutics, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: January 22, 2021 Approved by the Stockholders: January 25, 2021
12/34/56
EX-10.6
from S-1/A 6 pages Bolt Biotherapeutics, Inc. Rsu Award Grant Notice
12/34/56
EX-10.5
from S-1/A 7 pages Bolt Biotherapeutics, Inc. 2021 Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.4
from S-1/A 32 pages Bolt Biotherapeutics, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: January 22, 2021 Approved by the Stockholders: January 25, 2021
12/34/56
EX-10.2
from S-1/A 18 pages Bolt Biotherapeutics, Inc. (Fka Bolt Therapeutics, Inc.) Amended and Restated 2015 Equity Incentive Plan Original Plan Adopted by the Board of Directors: April 20, 2015 Original Plan Approved by the Stockholders: April 20, 2016 Amended and Restated Plan Adopted by the Board of Directors: September 17, 2016 Amended and Restated Plan Adopted by the Stockholders: September 21, 2016 Amended and Restated Plan Adopted by the Board of Directors: July 25, 2018 Amended and Restated Plan Adopted by the Stockholders: July 25, 2018 Amended and Restated Plan Adopted by the Board of Directors: June 26, 2019 Amended and Restated Plan Adopted by the Stockholders: June 28, 2019 Amended and Restated Plan Adopted by the Board of Directors: June 26, 2020 Amended and Restated Plan Adopted by the Stockholders: June 28, 2020 Amended by the Compensation Committee: September 3, 2020
12/34/56
EX-10.24
from S-1 19 pages Bolt Biotherapeutics, Inc. Severance and Change in Control Plan Approved by the Board of Directors: , 2021
12/34/56
EX-10.23
from S-1 24 pages Master Services Agreement
12/34/56
EX-10.22
from S-1 22 pages Supply Agreement
12/34/56
EX-10.21
from S-1 22 pages Exclusive Agreement
12/34/56
EX-10.20
from S-1 27 pages Exclusive (Equity) Agreement
12/34/56
EX-10.19
from S-1 91 pages Britannia Seaport Centre Lease
12/34/56
EX-10.18
from S-1 62 pages Consent to Sublease Agreement
12/34/56
EX-10.17
from S-1 54 pages Sublease Agreement
12/34/56